Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06948591 · ClinicalTrials.gov registry record
BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures
A clinical trial of ACL Tears, sponsored by CONMED Corporation.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT06948591 is a study of ACL Tears that is actively recruiting participants, run by CONMED Corporation. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06948591, a study of ACL Tears, is actively recruiting participants, sponsored by CONMED Corporation.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study will evaluate mid-term clinical safety and performance outcomes of the BioBrace® Reinforced Implant when used to augment a tissue graft during anterior cruciate ligament (ACL) reconstruction.
Conditions Studied
Interventions
- DEVICE Anterior cruciate ligament reconstruction with BioBrace® augmentation
- PROCEDURE Arthroscopic anterior cruciate ligament reconstruction
Study Locations (1)
Connecticut
- ConMed - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-04-08 |
| Est. Completion | 2030-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06948591
The ClinicalTrials.gov registry entry for NCT06948591 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CONMED Corporation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with ACL Tears appearing as the primary indexed condition, and to 2 interventions - of which Anterior cruciate ligament reconstruction with BioBrace® augmentation is the first listed.
NCT06948591 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT06948591 about?
NCT06948591 is a clinical study titled "BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures". This research study will evaluate mid-term clinical safety and performance outcomes of the BioBrace® Reinforced Implant when used to augment a tissue graft during anterior cruciate ligament (ACL) reconstruction.
What is the current status of trial NCT06948591?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2025-04-08. Estimated completion is 2030-06.
What conditions does trial NCT06948591 study?
This clinical trial studies the following conditions: ACL Tears.
What interventions are being tested in trial NCT06948591?
The interventions under investigation include: Anterior cruciate ligament reconstruction with BioBrace® augmentation (DEVICE), Arthroscopic anterior cruciate ligament reconstruction (PROCEDURE).
Who is sponsoring clinical trial NCT06948591?
This trial is sponsored by CONMED Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06948591 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.